Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics

Bacterial infections and antimicrobial resistance are posing substantial difficulties to the worldwide healthcare system. The constraints of conventional diagnostic and therapeutic approaches in dealing with continuously changing infections highlight the necessity for innovative solutions. Aptamers,...

Full description

Saved in:
Bibliographic Details
Main Authors: Zijian Ye, Huaizhi Chen, Harrie Weinans, Bart van der Wal, Jaqueline Lourdes Rios
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/9/1140
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850259860766064640
author Zijian Ye
Huaizhi Chen
Harrie Weinans
Bart van der Wal
Jaqueline Lourdes Rios
author_facet Zijian Ye
Huaizhi Chen
Harrie Weinans
Bart van der Wal
Jaqueline Lourdes Rios
author_sort Zijian Ye
collection DOAJ
description Bacterial infections and antimicrobial resistance are posing substantial difficulties to the worldwide healthcare system. The constraints of conventional diagnostic and therapeutic approaches in dealing with continuously changing infections highlight the necessity for innovative solutions. Aptamers, which are synthetic oligonucleotide ligands with a high degree of specificity and affinity, have demonstrated significant promise in the field of bacterial infection management. This review examines the use of aptamers in the diagnosis and therapy of bacterial infections. The scope of this study includes the utilization of aptasensors and imaging technologies, with a particular focus on their ability to detect conditions at an early stage. Aptamers have shown exceptional effectiveness in suppressing bacterial proliferation and halting the development of biofilms in therapeutic settings. In addition, they possess the capacity to regulate immune responses and serve as carriers in nanomaterial-based techniques, including radiation and photodynamic therapy. We also explore potential solutions to the challenges faced by aptamers, such as nuclease degradation and in vivo instability, to broaden the range of applications for aptamers to combat bacterial infections.
format Article
id doaj-art-85d13ded0b4043b09b1a077e77e37d9c
institution OA Journals
issn 1999-4923
language English
publishDate 2024-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-85d13ded0b4043b09b1a077e77e37d9c2025-08-20T01:55:46ZengMDPI AGPharmaceutics1999-49232024-08-01169114010.3390/pharmaceutics16091140Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to TherapeuticsZijian Ye0Huaizhi Chen1Harrie Weinans2Bart van der Wal3Jaqueline Lourdes Rios4Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The NetherlandsBacterial infections and antimicrobial resistance are posing substantial difficulties to the worldwide healthcare system. The constraints of conventional diagnostic and therapeutic approaches in dealing with continuously changing infections highlight the necessity for innovative solutions. Aptamers, which are synthetic oligonucleotide ligands with a high degree of specificity and affinity, have demonstrated significant promise in the field of bacterial infection management. This review examines the use of aptamers in the diagnosis and therapy of bacterial infections. The scope of this study includes the utilization of aptasensors and imaging technologies, with a particular focus on their ability to detect conditions at an early stage. Aptamers have shown exceptional effectiveness in suppressing bacterial proliferation and halting the development of biofilms in therapeutic settings. In addition, they possess the capacity to regulate immune responses and serve as carriers in nanomaterial-based techniques, including radiation and photodynamic therapy. We also explore potential solutions to the challenges faced by aptamers, such as nuclease degradation and in vivo instability, to broaden the range of applications for aptamers to combat bacterial infections.https://www.mdpi.com/1999-4923/16/9/1140aptamersbacterial infectionsantimicrobial resistancebiosensorsbiofilm
spellingShingle Zijian Ye
Huaizhi Chen
Harrie Weinans
Bart van der Wal
Jaqueline Lourdes Rios
Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics
Pharmaceutics
aptamers
bacterial infections
antimicrobial resistance
biosensors
biofilm
title Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics
title_full Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics
title_fullStr Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics
title_full_unstemmed Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics
title_short Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics
title_sort novel aptamer strategies in combating bacterial infections from diagnostics to therapeutics
topic aptamers
bacterial infections
antimicrobial resistance
biosensors
biofilm
url https://www.mdpi.com/1999-4923/16/9/1140
work_keys_str_mv AT zijianye novelaptamerstrategiesincombatingbacterialinfectionsfromdiagnosticstotherapeutics
AT huaizhichen novelaptamerstrategiesincombatingbacterialinfectionsfromdiagnosticstotherapeutics
AT harrieweinans novelaptamerstrategiesincombatingbacterialinfectionsfromdiagnosticstotherapeutics
AT bartvanderwal novelaptamerstrategiesincombatingbacterialinfectionsfromdiagnosticstotherapeutics
AT jaquelinelourdesrios novelaptamerstrategiesincombatingbacterialinfectionsfromdiagnosticstotherapeutics